Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma

Archives of Gynecology and Obstetrics

Volumn 276, Issue 2, 2007, Pages 179-183

  Hubalek, Michael ^a   Smekal Schindelwig, Caecilia ^a   Zeimet, Alain G ^a   Sergi, Consolato ^b   Brezinka, Christoph ^a   Mueller Holzner, Elisabeth ^a   Marth, Christian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Carboplatin; Chemotherapy; Conservative treatment; Ovarian dysgerminoma; Paclitaxel; Pregnancy

Indexed keywords

ANTIEMETIC AGENT; CA 125 ANTIGEN; CARBOPLATIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADULT; ADVANCED CANCER; ALOPECIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CESAREAN SECTION; CHILD DEVELOPMENT; DYSGERMINOMA; FEMALE; GESTATIONAL AGE; HUMAN; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; NAUSEA; OMENTECTOMY; POSTOPERATIVE CARE; SALPINGOOOPHORECTOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; FEMALE; GERMINOMA; HUMANS; INFANT, NEWBORN; MALE; OVARIAN NEOPLASMS; PACLITAXEL; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME;

EID: 34347385706     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-007-0328-2     Document Type: Article

References (17)

1. Antonelli NM et al (1996) Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv 51(2):125-134
2. Smith LH et al (2003) Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 189(4):1128-1135
3. Novak ER, Lambrou CD, Woodruff JD (1975) Ovarian tumors in pregnancy. An ovarian tumor registry review. Obstet Gynecol 46(4):401-406
4. Doll DC, Ringenberg QS, Yarbro JW (1989) Antineoplastic agents and pregnancy. Semin Oncol 16(5):337-346
5. Zemlickis D et al (1992) Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152(3):573-576
6. Williams SF, Bitran JD (1985) Cancer and pregnancy. Clin Perinatol 12(3):609-623
7. Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5(5):283-291
8. Oehler MK, Wain GV, Brand A (2003) Gynaecological malignancies in pregnancy: a review. Aust NZ J Obstet Gynaecol 43(6):414-420
9. Partridge AH, Garber JE (2000) Long-term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol 27(6):712-726
10. Mizejewski GJ (2003) Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv 58(12):804-826
11. Elit L et al (1999) An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol 72(1):123-127
12. Han JY et al (2005) Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod Toxicol 19(4):557-561
13. Brewer M et al (1999) Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17(9):2670-2675
14. De Giorgi U et al (2004) Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience. Am J Clin Oncol 27(5):457-460
15. Sood AK, Shahin MS, Sorosky JI (2001) Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 83(3):599-600
16. Mendez LE et al (2003) Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol 102(5 Pt 2):1200-1202
17. Gemma R et al (1992) Lactate dehydrogenase (LDH)-linked immunoglobulin in a patient with Graves' disease treated with methimazole. Intern Med 31(3):377-379